ALX ONCOLOGY HOLDINGS INC Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alx Oncology Holdings Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • Alx Oncology Holdings Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$30.7M, a 39.8% increase year-over-year.
  • Alx Oncology Holdings Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$151M, a 3.5% decline year-over-year.
  • Alx Oncology Holdings Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$161M, a 30.2% decline from 2022.
  • Alx Oncology Holdings Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$123M, a 47.9% decline from 2021.
  • Alx Oncology Holdings Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$83.5M, a 82.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$161M -$37.3M -30.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$123M -$40M -47.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$83.5M -$37.7M -82.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$45.7M -$26.5M -138% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 -$19.2M -$5.51M -40.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$13.7M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.